z-logo
open-access-imgOpen Access
Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies
Author(s) -
Delphine Vezzosi,
Antoine Bennet,
Philippe Rochaix,
F. Courbon,
J. Selves,
B. Pradère,
Étienne Buscail,
Christiane Susini,
Philippe Caron
Publication year - 2005
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje.1.01901
Subject(s) - octreotide , insulinoma , medicine , somatostatin receptor , scintigraphy , somatostatin , endocrinology , insulin
We studied the efficacy of octreotide treatment on hypoglycaemia in patients with insulinoma and its relationships with Octreoscan scintigraphy and the presence of tumoral somatostatin receptors sst2A and sst5.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom